Announcement on Valuation of Residual Value

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited (the stock exchange) take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Non-Collateralised Structured Products

Notice of Valuation of Residual Value of European Style (Cash Settled) Category R Callable Bull/Bear Contracts (the CBBCs)

issued by

CREDIT SUISSE AG (incorporated with limited liability under the laws of Switzerland)

Sponsor/Manager CREDIT SUISSE (HONG KONG) LIMITED

Terms not defined in this announcement have the same meaning as defined in the general conditions and the product conditions of the CBBCs (together, the conditions).

Credit Suisse AG (the issuer) announces that under the conditions, following the occurrence of a mandatory call event (MCE) in respect of the CBBCs described in the table below in the pre- opening session or the continuous trading session or the closing auction session (as the case may be) of the stock exchange at the time (MCE time) and on the date (MCE date) specified in the table below, the amount of the residual value in respect of the CBBCs has been determined as follows: Stock Type MCE MCE Underlying Issue Size Number of Entitlement Board Lot Strike Maximum/ Residual Value Code Time Date (CBBCs) CBBC(s) (CBBCs) Price Minimum Trade per Board Lot per (HK$) Price (HK$) (HK$) Entitlement 52208 Bull 11:02:46 6 Jul 2021 Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 114.88 116.50 81.0000 52685 Bull 10:56:38 6 Jul 2021 WuXi Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 118.00 116.50 0.0000 53127 Bull 09:30:24 6 Jul 2021 WuXi Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 128.00 116.50 0.0000 53134 Bull 10:12:41 6 Jul 2021 WuXi Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 124.88 116.50 0.0000 54329 Bull 09:30:12 6 Jul 2021 WuXi Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 130.88 116.50 0.0000 54330 Bull 10:45:34 6 Jul 2021 WuXi Biologics (Cayman) Inc. 50,000,000 100 1.00 Share(s) 5,000 121.88 116.50 0.0000 55802 Bull 10:57:44 6 Jul 2021 Sino Biopharmaceutical Limited 40,000,000 10 1.00 Share(s) 10,000 6.60 6.98 380.0000 60465 Bull 09:36:27 6 Jul 2021 Automobile Holdings 100,000,000 50 1.00 Share(s) 5,000 23.50 23.70 20.0000 Limited 60469 Bull 09:20:12 6 Jul 2021 Hong Kong Exchanges and 50,000,000 100 1.00 Share(s) 10,000 460.00 455.80 0.0000 Clearing Limited 60473 Bull 09:20:12 6 Jul 2021 Corporation 100,000,000 50 1.00 Share(s) 10,000 26.60 25.50 0.0000 60476 Bull 09:20:12 6 Jul 2021 100,000,000 500 1.00 Share(s) 5,000 317.00 277.00 0.0000 60482 Bull 09:39:38 6 Jul 2021 Galaxy Entertainment Group 80,000,000 100 1.00 Share(s) 10,000 60.08 60.55 47.0000 Limited 60486 Bull 09:20:12 6 Jul 2021 JD.com, Inc. 100,000,000 500 1.00 Share(s) 2,500 295.00 289.20 0.0000 62915 Bull 09:47:09 6 Jul 2021 Kuaishou Technology 100,000,000 500 1.00 Share(s) 5,000 165.00 167.70 27.0000 64974 Bull 09:41:53 6 Jul 2021 Semiconductor Manufacturing 50,000,000 50 1.00 Share(s) 2,500 21.28 21.75 23.5000 International Corporation

In respect of each board lot of Bull CBBCs, the residual value is an amount in Hong Kong dollars calculated by the issuer in accordance with the following formula:

Entitlement x (Minimum Trade Price - Strike Price) x one Board Lot Number of CBBC(s) per Entitlement

In respect of each board lot of Bear CBBCs, the residual value is an amount in Hong Kong dollars calculated by the issuer in accordance with the following formula:

Entitlement x (Strike Price – Maximum Trade Price) x one Board Lot Number of CBBC(s) per Entitlement

Subject to the occurrence of a settlement disruption event, all holders will receive the residual value (net of any exercise expenses) (if any) no later than July 09, 2021, which is three CCASS settlement days following the end of the MCE valuation period.

Credit Suisse AG July 6, 2021